Identification and control of a poliomyelitis outbreak in Xinjiang, China.

BACKGROUND The last case of infection with wild-type poliovirus indigenous to China was reported in 1994, and China was certified as a poliomyelitis-free region in 2000. In 2011, an outbreak of infection with imported wild-type poliovirus occurred in the province of Xinjiang. METHODS We conducted an investigation to guide the response to the outbreak, performed sequence analysis of the poliovirus type 1 capsid protein VP1 to determine the source, and carried out serologic and coverage surveys to assess the risk of viral propagation. Surveillance for acute flaccid paralysis was intensified to enhance case ascertainment. RESULTS Between July 3 and October 9, 2011, investigators identified 21 cases of infection with wild-type poliovirus and 23 clinically compatible cases in southern Xinjiang. Wild-type poliovirus type 1 was isolated from 14 of 673 contacts of patients with acute flaccid paralysis (2.1%) and from 13 of 491 healthy persons who were not in contact with affected persons (2.6%). Sequence analysis implicated an imported wild-type poliovirus that originated in Pakistan as the cause of the outbreak. A public health emergency was declared in Xinjiang after the outbreak was confirmed. Surveillance for acute flaccid paralysis was enhanced, with daily reporting from all public and private hospitals. Five rounds of vaccination with live, attenuated oral poliovirus vaccine (OPV) were conducted among children and adults, and 43 million doses of OPV were administered. Trivalent OPV was used in three rounds, and monovalent OPV type 1 was used in two rounds. The outbreak was stopped 1.5 months after laboratory confirmation of the index case. CONCLUSIONS The 2011 outbreak in China showed that poliomyelitis-free countries remain at risk for outbreaks while the poliovirus circulates anywhere in the world. Global eradication of poliomyelitis will benefit all countries, even those that are currently free of poliomyelitis.

[1]  Y. Chiba,et al.  Active surveillance for acute flaccid paralysis in poliomyelitis high-risk areas in southern China. , 2001, Bulletin of the World Health Organization.

[2]  Wenbo Xu,et al.  Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission. , 2010, The Journal of infectious diseases.

[3]  N. Grassly,et al.  Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study , 2007, The Lancet.

[4]  R. Linkins,et al.  The effect of diarrhea on oral poliovirus vaccine failure in Brazil. , 1997, The Journal of infectious diseases.

[5]  D. Kromhout,et al.  Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. , 1996, American journal of epidemiology.

[6]  M. Mulders,et al.  Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93 , 1994, The Lancet.

[7]  Wenbo Xu,et al.  An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. , 2006, The Journal of infectious diseases.

[8]  J. Puliyel,et al.  Protective efficacy of a monovalent oral type 1 poliovirus vaccine , 2007, The Lancet.

[9]  M. L. Ciofi Degli Atti,et al.  Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  B. Aylward,et al.  The global polio eradication initiative: lessons learned and prospects for success. , 2011, Vaccine.

[11]  Klaudia Porten,et al.  Poliomyelitis Outbreak,Pointe-Noire, Republic of the Congo, September 2010–February 2011 , 2011, Emerging infectious diseases.

[12]  A. V. van Loon,et al.  Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands. , 2001, The Journal of infectious diseases.